Improved survival in patients with unresectable stage III EGFR ‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors
暂无分享,去创建一个
W. Su | P. Su | Chien-Chung Lin | Y. Tseng | Y. Yen | S. Yang | Chia-Ying Lin | Chian-Wei Chen | Chao-Chun Chang | Sheng-Yuan Wang | Ching-Han Lai